You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carmustine and thiotepa

Showing 1 - 25 of 156
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)

Recruiting
  • Primary CNS Lymphoma
  • Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
  • Moscow, Russian Federation
    Nathional Medical Research Center for Hematology
Jun 16, 2022

Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)

Recruiting
  • Secondary Central Nervous System Lymphoma
  • Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
  • Beijing, Beijing, China
    Peking University Cancer Hospital & Institute
May 25, 2022

Glioblastoma Multiforme Trial in Baltimore (Retifanlimab, Temozolomide, Radiation Therapy)

Recruiting
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
Dec 5, 2022

Relapsed or Refractory (R/R) Primary CNS Lymphoma Trial in Nanjing (thiotepa combined with pomalidomide)

Recruiting
  • Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma
  • thiotepa combined with pomalidomide
  • Nanjing, Jiangsu, China
    Jiangsu Province People's Hospital.
Jun 27, 2023

Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma, Stage IV Choroidal and Ciliary Body Melanoma AJCC V8 Trial

Recruiting
  • Metastatic Malignant Neoplasm in the Liver
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy
Nov 16, 2022

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

Autologous Stem Cell Transplantation, Conditioning Trial in Xi'an (modified BEAM, BEAM)

Not yet recruiting
  • Autologous Stem Cell Transplantation
  • Conditioning
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Apr 14, 2023

Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)

Completed
Has Results
  • Lymphoma
  • HIV
  • Autologous transplant
  • +4 more
  • Duarte, California
  • +15 more
Dec 6, 2022

Early Pulmonary Dysfunction in Childhood Cancer Patients

Recruiting
  • Pulmonary Dysfunction
  • Lung function measurements
  • +5 more
  • Basel, Switzerland
  • +4 more
Jun 15, 2022

Recurrent DLBCL, Recurrent DLBCL, Not Otherwise Specified, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6

Withdrawn
  • Recurrent Diffuse Large B-Cell Lymphoma
  • +9 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem

Active, not recruiting
  • Hematologic Malignancies
  • +7 more
  • San Francisco, California
    University of California, San Francisco
Feb 28, 2022

Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

Recruiting
  • Autoimmune Disease
  • +18 more
  • Anti-Thymocyte Globulin
  • +9 more
  • Denver, Colorado
  • +2 more
Feb 1, 2023

Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

Recruiting
  • Ewing's Family Tumors
  • +11 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Apr 11, 2022

Lymphoma Trial in United States (carmustine, cytarabine, etoposide)

Active, not recruiting
  • Lymphoma
  • Anchorage, Alaska
  • +125 more
Aug 16, 2021

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

CNS Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Xi'an (TBF regimen, modified BuCY2 regimen)

Not yet recruiting
  • Central Nervous System Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • TBF regimen
  • modified BuCY2 regimen
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022

Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

Recruiting
  • Sickle Cell Disease
  • Bone Marrow Transplant (BMT)
  • +7 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Sep 13, 2022

HLH Trial in Beijing (Thiotepa)

Recruiting
  • HLH
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
May 10, 2023

Lymphoma Trial in Duarte (drug, other, procedure)

Active, not recruiting
  • Lymphoma
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
    • (no location specified)
    Nov 1, 2023

    Stem Cell Transplant Complications, Graft Vs Host Disease, Myeloid Leukemia, Acute Trial in Boston (radiation, drug, biological,

    Recruiting
    • Stem Cell Transplant Complications
    • +4 more
    • Radiation
    • +7 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jan 19, 2023

    Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

    Recruiting
    • Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer Center, Case Comprehensive C
    Jan 24, 2022

    Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,

    Not yet recruiting
    • Acute Leukemia of Ambiguous Lineage
    • +8 more
    • Biospecimen Collection
    • +12 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Aug 22, 2023

    Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

    Recruiting
    • Cytarabine+Thiotepa + Fludarabine + Busulfan
    • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • cytarabine+thiotepa+ fludarabine + busulfan
    • Hangzhou, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Oct 26, 2022

    Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

    Completed
    Has Results
    • Glioblastoma
    • Gliosarcoma
    • 3-Dimensional Conformal Radiation Therapy
    • +10 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 4, 2022